AINewsnow

Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

Phylo, Inc. announced on October 22, 2026, a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI platform, to accelerate scientific research and evaluation, with Bayer scientists gaining full access for literature and omics evidence workflows in drug discovery. The Bayer Partnership Und…

Read the full story at Unite.AI ↗

Timeline · 1 report

  1. 2026-10-22 16:24 · Unite.AI
    Phylo Partners With Bayer on Biomni Lab AI Agents for Drug Research

More stories

  1. OlmoEarth v1.3: State-of-the-art embeddings for the whole planet — Allen Institute for AI (Ai2)
  2. Uber brings ChatGPT Work to all employees with OpenAI — OpenAI News
  3. Claude Duet is Anthropic's answer to Meta Muse and OpenAI Dots — Engadget
  4. Write your own training loop — without managing GPUs — with Amazon SageMaker training session APIs — AWS Machine Learning Blog
  5. Stop guessing auto scaling targets for TTS on Amazon SageMaker AI — AWS Machine Learning Blog
  6. Cognition Becomes First Customer for NVIDIA Vera Rubin NVL72 on CoreWeave Cloud — CoreWeave Blog
  7. Ex-OpenAI Science Head Kevin Weil Launches Startup With $215 Million — Bloomberg AI
  8. Meta agrees deal to keep Zuckerberg in California despite wealth tax proposal — Financial Times AI

Get the daily brief of stories like this at 6:30 every morning →